Insiders · NLTX

NLTX insider transactions

Neoleukin Therapeutics Inc. (NLTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NLTX

• 874d
  SEC Form 4 filed by Woods Robert Keith

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Palekar Rohan

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Noonberg Sarah B.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Freedland Cory S.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Baffi Robert

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Jordan Julie

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 3 filed by new insider Jordan Julie

  3 - Neurogene Inc. (0001404644) (Issuer)
• 897d
  New insider Cvijic Christine Mikail claimed ownership of 20,941 shares (SEC Form 3)

  3 - Neurogene Inc. (0001404644) (Issuer)
• 897d
  New insider Mcminn Rachel claimed ownership of 1,250,359 shares (SEC Form 3)

  3 - Neurogene Inc. (0001404644) (Issuer)
• 897d
  SEC Form 3 filed by new insider Woods Robert Keith

  3 - Neurogene Inc. (0001404644) (Issuer)
• 897d
  SEC Form 3 filed by new insider Baffi Robert

  3 - Neurogene Inc. (0001404644) (Issuer)
• 897d
  SEC Form 3 filed by new insider Cobb Stuart

  3 - Neurogene Inc. (0001404644) (Issuer)
• 897d
  SEC Form 3 filed by new insider Freedland Cory S.

  3 - Neurogene Inc. (0001404644) (Issuer)
• 903d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Neurogene Inc. (0001404644) (Issuer)
• 974d
  Baker Bros. Advisors Lp converted options into 592,650 shares (SEC Form 4)

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1028d
  SEC Form 4: Baker Bros. Advisors Lp bought $1,463,487 worth of shares (2,285,342 units at $0.64)

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1031d
  SEC Form 4: Smith Sean Michael converted options into 5,000 shares and sold $818 worth of shares (1,323 units at $0.62), increasing direct ownership by 20% to 21,637 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1094d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Simpson Todd E

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Palekar Rohan

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Noonberg Sarah B.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Lavelle Erin

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Babler Martin

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1163d
  SEC Form 4 filed by Patel Priti

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1223d
  SEC Form 4: Smith Sean Michael converted options into 12,500 shares and sold $1,980 worth of shares (3,316 units at $0.60), increasing direct ownership by 136% to 15,960 units to cover taxes

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1223d
  SEC Form 4: Patel Priti converted options into 35,000 shares and sold $8,588 worth of shares (14,380 units at $0.60), increasing direct ownership by 197% to 31,082 units to cover withholding tax

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1398d
  SEC Form 4: Smith Sean Michael sold $1,641 worth of shares (1,655 units at $0.99) and converted options into 5,000 shares, increasing direct ownership by 97% to 6,776 units (withholding obligation)

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Walkey Carl

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Smith Sean Michael

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Patel Priti

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Drachman Jonathan G

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Cochener Donna

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Lavelle Erin

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Simpson Todd E

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Palekar Rohan

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Noonberg Sarah B.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Babler Martin

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1499d
  SEC Form 4: Patel Priti converted options into 10,000 shares and sold $6,749 worth of shares (5,538 units at $1.22), increasing direct ownership by 223% to 6,462 units (withholding tax)

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1548d
  SEC Form 4 filed by Cochener Donna

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1548d
  SEC Form 3 filed by new insider Cochener Donna

  3 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1559d
  SEC Form 4 filed by Palekar Rohan

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1559d
  SEC Form 3 filed by new insider Palekar Rohan

  3 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1560d
  SEC Form 3: New insider Smith Sean Michael claimed ownership of 3,431 shares

  3 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1560d
  SEC Form 4 filed by Smith Sean Michael

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1577d
  SEC Form 5: Drachman Jonathan G gifted 150,000 shares and received a gift of 150,000 shares, decreasing direct ownership by 3% to 2,198,686 units

  5 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1589d
  SEC Form 4 filed by Walkey Carl

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1589d
  SEC Form 4 filed by Patel Priti

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1589d
  SEC Form 4 filed by Ho Robert

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1749d
  SEC Form 4: Drachman Jonathan G bought $933,550 worth of Common Stock (150,000 units at $6.22), increasing direct ownership by 4% to 2,348,686 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1770d
  SEC Form 4 filed by Neoleukin Therapeutics, Inc.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1770d
  SEC Form 4 filed by Neoleukin Therapeutics, Inc.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1770d
  SEC Form 4 filed by Ho Robert

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1819d
  SEC Form 4: Walkey Carl sold $6,114 worth of Common Stock (600 units at $10.19), decreasing direct ownership by 0.04% to 1,352,489 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1825d
  SEC Form 4: Walkey Carl sold $7,036 worth of Common Stock (650 units at $10.82), decreasing direct ownership by 0.05% to 1,353,089 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1827d
  SEC Form 4: Walkey Carl sold $6,600 worth of Common Stock (600 units at $11.00), decreasing direct ownership by 0.04% to 1,353,739 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1829d
  SEC Form 4: Walkey Carl sold $6,000 worth of Common Stock (600 units at $10.00), decreasing direct ownership by 0.04% to 1,354,339 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1829d
  SEC Form 4 filed by Neoleukin Therapeutics, Inc.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1841d
  SEC Form 4: Walkey Carl sold $6,000 worth of Common Stock (600 units at $10.00), decreasing direct ownership by 0.04% to 1,354,939 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1854d
  SEC Form 4 filed by Williams Lewis T

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)